NEW YORK (360Dx) – Molecular diagnostics company iCubate today announced the US Food and Drug Administration has cleared its iC-System and iC-GPC assay for the rapid detection of pathogenic bacteria associated with bloodstream infections.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.